82 PART TWO | CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING 1. Bloechl-Daum B, Deuson RR, Mavros P et al. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 2006;24:4472-8. 2. Pirri C, Bayliss E, Trotter J et al. Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 2013;21:735-48. 3. Aapro M. CINV: still troubling patients after all these years. Support Care Cancer 2018;26(Suppl 1):5-9. 4. Ng TL, Hutton B, Clemons M. Chemotherapy-Induced nausea and vomiting: time for more emphasis on nausea? The Oncologist 2015;20:57683. 5. Molassiotis A, Saunders MP, Valle J et al. A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 2008;16:2018. 6. Escobar Y, Cajaraville G, Virizuela JA et al. Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study. Support Care Cancer 2015;23:2833-40. 7. Grunberg SM, Deuson RR, Mavros P et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 2004;100:2261-8. 8. Ihbe-Heffinger A, Ehlken B, Bernard R, et al. The impact of delayed chemotherapyinduced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Ann Oncol 2004;15:526-36. 9. Hernandez Torres C, Mazzarello S, Ng T et al. Defining optimal control of chemotherapy-induced nausea and vomiting based on patients’ experience. Support Care Cancer 2015;23:3341-59. 10. Salsman JM, Grunberg SM, Beaumont JL et al. Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Natl Compr Cancer Netw 2012;10:149-57. 11. Di Maio M, Gallo C, Leighl NB et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol 2015;33:910-15. 12. Janelsins MC, Tejani MA, Kamen C et al. Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert Opin Pharmacother 2013;14:757-66. 13. Roila F, Molassiotis A, Herrstedt J et al. 2016 MASCC and ESMO guideline update for the prevention of chemotherapyand radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 2016;27(suppl 5):v119-v33. 14. Hesketh PJ, Kris MG, Basch E et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2017;35:3240-61. 15. Italian Group for Antiemetic Research. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med 2000;342:1554-9. 16. Roscoe JA, Heckler CE, Morrow GR et al. Prevention of delayed nausea: a University of Rochester Cancer Center community clinical oncology program study of patients receiving chemotherapy. J Clin Oncol 2012;30:3389-95. References
RkJQdWJsaXNoZXIy MjY0ODMw